BioSpace News Archive

Drug Development

Laurantis Pharma Oy Release: Investigational Cis-urocanic Acid Eye Drops for Dry Eye Syndrome Well Tolerated, in Phase 1 Clinical Study

June 28, 2012
·
2 min read
Catalyst Pharmaceutical Partners, Inc. Release: Scientific Paper Describing the Ocular Safety of Short-Term Vigabatrin Treatment for Cocaine Addiction in Online Edition of American Journal of Ophthalmology

June 28, 2012
·
1 min read
Business

Hydromer, Inc. Enters Into a Strategic Development Agreement With N8 Medical Inc. for a New Class of Antimicrobial Coatings

June 28, 2012
·
3 min read
Pharm Country

CAS Medical Systems, Inc. Announces Publication of Study Using FORE-SIGHT(R) to Improve Identification of Children With Sickle Cell Disease at Highest Risk for Neurologic Injury in Pediatric Blood and Cancer Journal

June 28, 2012
·
1 min read
Deals

Tesaro, Inc. Announces Pricing of Initial Public Offering

June 28, 2012
·
1 min read
Genetown

Coronado Biosciences Announces Closing of $28.8 Million Public Offering

June 28, 2012
·
1 min read
Drug Development

Merrimack Pharmaceuticals Inc. Announces Expansion of Phase 3 NAPOLI-1 Study of MM-398 in Late Stage Pancreatic Cancer

June 28, 2012
·
1 min read
BioMidwest

Aastrom Biosciences, Inc. Announces Common Stock Exchange for December 2010 Warrants

June 28, 2012
·
1 min read
Drug Development

Spherix Reports Findings From New Study in Mice Showing SPX106T Yields Significant Reductions in Serum VLDL

June 28, 2012
·
1 min read
Biotech Bay

BioCentury Publications Inc. Wins Mediscience Commentator of the Year Award

June 28, 2012
·
2 min read